Patents by Inventor Peter W. Glunz

Peter W. Glunz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cycloalkyl heterocycles for treating hepatitis C virus
    Patent number: 7112601
    Abstract: Compounds of Formula I are disclosed which inhibit hepatitis C NS5B RNA-dependent RNA polymerase and are useful for treating hepatitis C.
    Type: Grant
    Filed: August 19, 2004
    Date of Patent: September 26, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter W. Glunz, Brent D. Douty, Scott W. Martin, Jeffrey Romine
  • Bicyclic pyrimidinones as coagulation cascade inhibitors
    Patent number: 7094783
    Abstract: The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel amino-bicyclic pyrimidinone compounds of Formula (I): or a stereoisomer or pharmaceutically acceptable salt form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor Xa, factor XIa, factor IXa, and/or factor VIIa. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: August 22, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventor: Peter W. Glunz
  • Phenylglycine derivatives useful as serine protease inhibitors
    Publication number: 20040204412
    Abstract: Compounds having the formula (I), 1
    Type: Application
    Filed: February 10, 2004
    Publication date: October 14, 2004
    Inventors: Peter W. Glunz, Gregory S. Bisacchi, George C. Morton, Alexandra A. Holubec, E. Scott Priestley, Xiaojun Zhang, Uwe D. Treuner
  • Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
    Patent number: 6727366
    Abstract: The present invention relates generally to a novel class of imidazolidinones of Formula (I): that are useful as serine protease inhibitors, and more particularly as Hepatitis C virus NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    Type: Grant
    Filed: December 12, 2001
    Date of Patent: April 27, 2004
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Amy Qi Han, Peter W. Glunz
  • Bicyclic pyrimidinones as coagulation cascade inhibitors
    Publication number: 20040006065
    Abstract: The present invention relates generally to compounds that inhibit serine proteases.
    Type: Application
    Filed: June 19, 2003
    Publication date: January 8, 2004
    Inventor: Peter W. Glunz
  • Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors
    Publication number: 20030100768
    Abstract: The present invention relates generally to a novel class of imidazolidinones of Formula (I): 1
    Type: Application
    Filed: December 12, 2001
    Publication date: May 29, 2003
    Inventors: Amy Qi Han, Peter W. Glunz